APA (7th ed.) Citation

Kümmel, S., Jung, K. H., Andrade, L., Assad-Suzuki, D., de la Cruz Merino, L., Freitas-Junior, R., . . . Hamilton, E. P. (2025). Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: A phase Ib study. ESMO open, 10(12), . https://doi.org/10.1016/j.esmoop.2025.105869

Chicago Style (17th ed.) Citation

Kümmel, Sherko, et al. "Safety and Efficacy of Tiragolumab, Atezolizumab and Chemotherapy for Early-stage or PD-L1-positive Advanced Triple-negative Breast Cancer: A Phase Ib Study." ESMO Open 10, no. 12 (2025). https://doi.org/10.1016/j.esmoop.2025.105869.

MLA (9th ed.) Citation

Kümmel, Sherko, et al. "Safety and Efficacy of Tiragolumab, Atezolizumab and Chemotherapy for Early-stage or PD-L1-positive Advanced Triple-negative Breast Cancer: A Phase Ib Study." ESMO Open, vol. 10, no. 12, 2025, https://doi.org/10.1016/j.esmoop.2025.105869.